Our people
Unhindr's C-suite, every discipline a deeptech wearables company needs. A biomedical engineer and entrepreneur at heart (Imperial) and a soft-robotics scientist (Harvard) co-founded the company; a software lead and an operations lead round it out. Four executives. Four disciplines. One platform, ten years in the making.
Recognition
A decade of research, validation and partnership has earned Unhindr recognition from some of the UK's and Europe's most respected institutions in engineering, health innovation and deep-tech investment.
Selected by the Royal Academy of Engineering for its prestigious Enterprise Fellowship - a year of mentorship, funding and training to turn breakthrough engineering research into a commercial venture.
Named by EIT Health as a standout success story from its pan-European portfolio - highlighting Unhindr's journey from lab innovation to clinically validated wearable platform.
Awarded three consecutive Innovate UK Smart Grants - funding the development, validation and scaling of our adaptive metamaterial platform through successive R&D milestones.
EIT Health
Selected among Europe's most promising healthtech ideas by the EIT Health innovation community - a pan-European programme backing high-impact medical ventures.
Imperial College London
Project Roliner was awarded the Societal Award by the President. This recognition highlights our commitment to involving the public and the impressive international impact of our work on prosthetics.
Mayor of London
Revolutionising the future of prosthetics, Ugur and his team won the Mayor's Entrepreneur of the Year Award in the Health category for their pioneering startup.
SEHTA
Selected as the most innovative start-up in the London Region by South East Healthcare Tech Alliances (SEHTA).
Baker Botts
Selected by a panel of venture capital investors as best pitch of the cohort - recognising our team's exceptional communication skills.
MedCity
Named MedCity's Company of the Month - highlighting Unhindr's early success in developing adaptive wearable technology for amputees. This accolade recognised the startup's rapid transition from a university concept into a promising venture backed by the MedTech SuperConnector and Innovate UK.
Baker Botts
Selected by a panel of venture capital investors as the most investable startup of the cohort - recognising both the science and the market opportunity.
Our partners
